Mon.Jan 27, 2025

article thumbnail

GSK backs £50m Oxford University cancer vaccine programme

pharmaphorum

A GSK alliance with Oxford University aims to identify precancerous changes in cells that could form the basis of preventive vaccines.

118
118
article thumbnail

DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video)

MedCity News

The AI race heats up with a new kid on the block from China. How did it compare against a popular U.S. genAI engine on a simple healthcare industry question? The post DeepSeek v. ChatGPT: Why is healthcare so expensive in America? (Video) appeared first on MedCity News.

article thumbnail

An ALS treatment wave is approaching, and this biotech CEO is ready to surf

PharmaVoice

Coya Therapeutics is entering into a phase 2b study for its ALS, and the biotech’s CEO believes it’s on the cusp of a game changer.

105
105
article thumbnail

Pfizer offers $60m to settle prescriber kickback claims

pharmaphorum

Pfizer has paid $60m to settle US government allegations that its Biohaven unit made improper payments to prescribers of its migraine drug Nurtec ODT.

article thumbnail

AI in Marketing & Sales: Today’s Tools, Tomorrow’s Potential

Speaker: Kevin Burke

AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.

article thumbnail

Pfizer settles Biohaven kickback claims case for $59.7m

Pharmaceutical Technology

Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.

article thumbnail

Ascentage raises $126m in first biotech IPO of 2025

pharmaphorum

China's Ascentage completes the first US biotech IPO of 2025, raising $126m for its pipeline of small-molecule cancer drugs.

98

More Trending

article thumbnail

UK biotech Swarm lands with a T-cell therapy mission

pharmaphorum

UK firm Swarm Oncology launches with a T-cell therapy platform to treat solid tumours, with a Resolution Therapeutics co-founder in the pilot seat.

83
article thumbnail

Bridging the Gap Between Herbal Wisdom and Scientific Research

MedCity News

What if these two worlds werent at odds? What if they were two parts of the same story, waiting to be brought together for the benefit of all? The post Bridging the Gap Between Herbal Wisdom and Scientific Research appeared first on MedCity News.

article thumbnail

Natural killer cells, a rising alternative to CAR-T cell therapy

PharmaVoice

These innate immune cells may provide a safer, lower-cost option in cancer and autoimmune diseases.

69
article thumbnail

Tevogen Bio and Microsoft expand AI collaboration to PredicTcell tech

Pharmaceutical Technology

Tevogen Bio has expanded its partnership with Microsoft, aiming to further their collaboration centred on AI and advance PredicTcell.

69
article thumbnail

5 Ways You Can Win Faster with Gen AI in Sales

Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.

article thumbnail

Vedanta Biosciences reveals Phase 2 VE303 results

PharmaTimes

Study highlights VE303's potential in reducing recurrent CDI

66
article thumbnail

The AI advantage in discovering new medicines 

Pharmaceutical Technology

With continued investment and growing buzz from the industry, the AI hype is expected to extend through 2025 and beyond.

article thumbnail

Alligator Bioscience reports survival benefit of mitazalimab with mFOLFIRINOX

PharmaTimes

Comparison shows improved survival rates for pancreatic cancer treatment

63
article thumbnail

Italian decision sets up launch of Oncopeptides' Pepaxti

pharmaphorum

Oncopeptides hopes to reignite growth in multiple myeloma drug Pepaxti after getting reimbursement approval in Italy.

63
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Provepharm Recalls Phenylephrine Hydrochloride Injection

PharmaTech

One lot of Phenylephrine hydrochloride Injection, USP, 10 mg/mL is being recalled due to particulate matter found in a vial.

59
article thumbnail

FDA Accepts Review of Golimumab Biosimilar

Pharmaceutical Commerce

Known as AVT05, the Alvotech medication is a proposed biosimilar to Simponi, prescribed to treat various inflammatory conditions.

FDA 59
article thumbnail

Behind the Headlines: Sana’s Type 1 Diabetes Breakthrough, Drug Price Negotiations, and More

PharmaTech

Brian Feth, Jonathan Grinstein, PhD, Beth Willers, and Laks Pernenkil go behind the headlines to discuss major news announcements made during the JP Morgan Healthcare Conference, a wave of new Medicare drug price negotiations, and more.

article thumbnail

MSD wins FDA priority review for Welireg in rare endocrine cancer

Pharmaceutical Technology

If approved, Welireg would be the only available therapy in the US for eligible patients with advanced PPGL.

FDA 59
article thumbnail

10 Ways to Leverage Buyer Signals and Drive Revenue

In today’s ultra-competitive markets, it’s no longer enough to wait for buyers to show obvious signs of interest. Instead, sales teams must be proactive, identifying and acting on nuanced buyer behaviors — often before prospects are fully ready to make a purchase. In this eBook from ZoomInfo & Sell Better, learn 10 actionable ways to use these buyer signals to transform your sales strategy and close deals faster.

article thumbnail

FDA Grants Priority Review to Merck’s Welireg for Advanced, Unresectable, or Metastatic Pheochromocytoma, Paraganglioma

PharmExec

Priority review for Welireg is based on data from the Phase II LITESPARK-015 trial, which showed promising response rates in patients with advanced, unresectable, or metastatic pheochromocytoma and paraganglioma.

FDA 52
article thumbnail

Eisai and Biogen’s LEQEMBI sBLA set for Alzheimer’s maintenance dosing

Pharmaceutical Technology

The FDA has approved the sBLA of Eisai and Biogen's LEQEMBI for maintenance dosing indicated for the early stages of Alzheimer's.

FDA 59
article thumbnail

EMA Takes Break From X, Joins Bluesky

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

BIA report: UK biotech investment surged to £3.5bn in 2024

Pharmaceutical Technology

The UK biotech sector raised 3.5bn in 2024, the highest annual total since 2021 when 4.5bn was raised.

59
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

FDA Approves Supplemental Biologics License Application for Intravenous Maintenance Dosing of Leqembi in Alzheimer Disease

PharmExec

Approval was based on results from multiple studies, which demonstrated a slowing of cognitive decline in patients with Alzheimer disease administered Leqembi.

FDA 52
article thumbnail

Amgen opens new drug substance facility in North Carolina, US

Pharmaceutical Technology

Amgen has inaugurated its new drug substance facility in the US after announcing a $1bn further expansion at the North Carolina site.

59
article thumbnail

Key Factors for Choosing a 3PL Provider

Pharmaceutical Commerce

In the final part of her video interview with Pharma Commerce Editor Nicholas Saraceno, Amanda Salindong, associate director of channel & distribution at Alnylam Pharmaceuticals, shares the elements that manufacturers should consider when selecting a 3PL.

article thumbnail

Exploring Biopharma's Dealmaking Terrain, Roadmap in China

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Signal-Based Selling: How to Leverage 4 Key Buying Signals

As prospects define their problem, search for solutions, and even change jobs, they are generating high-value signals that the best go-to-market teams can leverage to close more deals. This is where signal-based selling comes into play. ZoomInfo CEO Henry Schuck recently broke down specific ways to put four key buying signals into action with the experts from 30 Minutes to President’s Club.

article thumbnail

Pharma Pulse 1/27/25: Digital Therapeutics with Abuse-Deterrent Pain Medication, Menopause Support and Workplace Change & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 52
article thumbnail

Preeclampsia Foundation Launches GAP—SPIRIN

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52
article thumbnail

Understanding the Impact of Guillain-Barré syndrome

Pharmatutor

Understanding the Impact of Guillain-Barr syndrome Pradip Mahajan Mon, 01/27/2025 - 15:41 Guillain-Barre syndrome (GBS) is an autoimmune disease. It's a rare neurological disorder that occurs when the body's immune system attacks its own peripheral nerves that carry signals from the brain and spinal cord to the rest of the body.

52
article thumbnail

Unifying Commercial Teams for Customer-Centric HCP Engagement: Q&A with Matt Farrell

PharmExec

Veevas vice president of commercial strategy discusses how streamlining their processes with a single goal in mind can improve their relationships with customers.

52
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven